Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...

MedGenome: Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both ...

A U.S. stock rally fueled by Donald Trump’s election victory is stumbling, as investors contend with everything from renewed ...

Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS ...

Wall Street continues its decline on Friday following the Fed Chairman’s hawkish statement on rate cut. Moreover, President-elect Donald Trump’s decision to elect a vaccine skeptic as the head of the ...

Shares are mixed in Asia after U.S. stocks fell to their worst loss since Election Day. Japan's benchmark lost 1% while ...

The S&P 500 fell 2% in the past week, erasing more than half its gains from a post-election surge fueled in part by optimism ...

Gift Nifty was trading around 23,495 level, a discount of nearly 105 points from the Nifty futures’ previous close, ...

Patients with GPA completely weaned off glucocorticoids were four times as likely to flare compared with those kept on a low ...

Nikolaos Komilionis was 66, and on holiday in Greece, when he was admitted to hospital for minor surgery. It should have been ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...